Zhejiang Huahai Approved for Generic HIV Drug

July 13, 2007 – Zhejiang Huahai Pharmaceutical Co. Ltd. (SSH:600521) won tentative approval from the FDA in the US for its generic form of nevirapine, an HIV/AIDS drug. Tentative approval is given to drugs that are still protected by patent. Nevirapine is a non-nucleoside reverse transcriptase inhibitor (NNRTI) that was originally approved in November 1996. It is indicated for use in combination with other antiretroviral agents and also among HIV-infected women to prevent mother-to-child-transmission of HIV. More details...

MORE ON THIS TOPIC